Selected article for: "disease severity and heart failure"

Author: Magadum, Ajit; Kishore, Raj
Title: Cardiovascular Manifestations of COVID-19 Infection
  • Cord-id: nte4xyft
  • Document date: 2020_11_19
  • ID: nte4xyft
    Snippet: SARS-CoV-2 induced the novel coronavirus disease (COVID-19) outbreak, the most significant medical challenge in the last century. COVID-19 is associated with notable increases in morbidity and death worldwide. Preexisting conditions, like cardiovascular disease (CVD), diabetes, hypertension, and obesity, are correlated with higher severity and a significant increase in the fatality rate of COVID-19. COVID-19 induces multiple cardiovascular complexities, such as cardiac arrest, myocarditis, acute
    Document: SARS-CoV-2 induced the novel coronavirus disease (COVID-19) outbreak, the most significant medical challenge in the last century. COVID-19 is associated with notable increases in morbidity and death worldwide. Preexisting conditions, like cardiovascular disease (CVD), diabetes, hypertension, and obesity, are correlated with higher severity and a significant increase in the fatality rate of COVID-19. COVID-19 induces multiple cardiovascular complexities, such as cardiac arrest, myocarditis, acute myocardial injury, stress-induced cardiomyopathy, cardiogenic shock, arrhythmias and, subsequently, heart failure (HF). The precise mechanisms of how SARS-CoV-2 may cause myocardial complications are not clearly understood. The proposed mechanisms of myocardial injury based on current knowledge are the direct viral entry of the virus and damage to the myocardium, systemic inflammation, hypoxia, cytokine storm, interferon-mediated immune response, and plaque destabilization. The virus enters the cell through the angiotensin-converting enzyme-2 (ACE2) receptor and plays a central function in the virus’s pathogenesis. A systematic understanding of cardiovascular effects of SARS-CoV2 is needed to develop novel therapeutic tools to target the virus-induced cardiac damage as a potential strategy to minimize permanent damage to the cardiovascular system and reduce the morbidity. In this review, we discuss our current understanding of COVID-19 mediated damage to the cardiovascular system.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acute coronary syndrome: 1
    • ace inhibitor and acute myocardial injury: 1
    • ace inhibitor and acute myocarditis: 1
    • ace inhibitor and adaptive immunity: 1
    • ace inhibitor and lung damage: 1
    • ace inhibitor and lung disease: 1
    • ace inhibitor and lung fibrosis: 1
    • ace inhibitor and lung injury: 1, 2, 3, 4
    • ace inhibitor angiotensin receptor blocker and acute ards respiratory distress syndrome: 1, 2, 3
    • ace inhibitor angiotensin receptor blocker and acute coronary syndrome: 1
    • ace inhibitor angiotensin receptor blocker and acute myocardial injury: 1
    • ace inhibitor angiotensin receptor blocker and acute myocarditis: 1
    • ace inhibitor angiotensin receptor blocker and lung damage: 1
    • ace inhibitor angiotensin receptor blocker and lung injury: 1, 2